Integrative omics approaches for new target identification and therapeutics development

[thumbnail of Kanapeckaite_thesis.pdf]
Preview
Text
- Thesis
[thumbnail of Kanapeckaite_form.pdf]
Text
- Thesis Deposit Form
· Restricted to Repository staff only

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Kanapeckaitė, A. (2022) Integrative omics approaches for new target identification and therapeutics development. PhD thesis, University of Reading. doi: 10.48683/1926.00113682

Abstract/Summary

The growing research and commercial pressures for novel therapeutics development accentuate why better strategies are needed for drug discovery. The costly nature of developing a pharmaceutical compound as well as the shrinking pool of ‘easy’ targets are some of the key reasons why there is a research paradigm shift towards integrative and systems biology driven approaches. Moreover, multifactorial aspects of many diseases require more innovative clinical strategies rather than just focusing on a single target. Cardiovascular diseases as well as associated immune components exemplify this complexity well. This thesis aimed to introduce a gradual and highly integrative analytical framework by incorporating a full range of studies from disease target selection to high-throughput virtual screening so that a cost-effective and efficient stratification of targets and associated compounds could be achieved. Heart failure served as a case study for complex diseases where the first in-depth omics study on cardiomyopathies helped to elucidate new therapeutic avenues. This research tied in with a development of a novel scoring function and integrated machine learning approach for multiple therapeutic target classification and exploration. Finally, all pieces of the introduced research were used to create a highly integrative in silico screening workflow. Some of the key results included the first reported molecular dynamics analyses for a complex immunotherapeutic target, c-Rel, as well as 15 new therapeutic compounds that could potentially modulate this transcription factor subunit. Thus, this dissertation provided several important improvements for target identification, validation, and drug discovery that could significantly advance current development strategies and accelerate new therapeutics production.

Altmetric Badge

Item Type Thesis (PhD)
URI https://centaur.reading.ac.uk/id/eprint/113682
Identification Number/DOI 10.48683/1926.00113682
Divisions Life Sciences > School of Chemistry, Food and Pharmacy
Date on Title Page December 2021
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record